Health & Science / Pharmaceuticals
Wegovy Approved for Liver Disease: A Breakthrough for MASH Treatment
Novo Nordisk's Wegovy has received U.S. FDA approval for treating metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis. This is a significant development as Wegovy becomes the first GLP-...